These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [Abstract] [Full Text] [Related]
3. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
8. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients. Hu HH, Liu J, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, Quan Y, Xia NS, Chen CJ, Chen PJ, Yang HI. Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083 [Abstract] [Full Text] [Related]
11. The detection of HBV DNA with polymerase chain reaction in blood donors with isolated hepatitis B core antibody. Tas T, Kaya S, Onal S, Kucukbayrak A. Med Glas (Zenica); 2012 Aug; 9(2):227-30. PubMed ID: 22926355 [Abstract] [Full Text] [Related]
12. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Kuhns MC, Busch MP. Mol Diagn Ther; 2006 Aug; 10(2):77-91. PubMed ID: 16669606 [Abstract] [Full Text] [Related]
13. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study. Alizadeh Z, Milani S, Sharifi Z. Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970 [Abstract] [Full Text] [Related]
14. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature. Hedayati-Moghaddam MR, Tehranian F, Mosavat A, Miri R, Ahmadi Ghezeldasht S. Arch Iran Med; 2024 Jun 01; 27(6):305-312. PubMed ID: 38855800 [Abstract] [Full Text] [Related]
15. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors. Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M. Virol J; 2016 Mar 05; 13():36. PubMed ID: 26944046 [Abstract] [Full Text] [Related]
16. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT. Baghbanian M, Halvani M, Roghani HS, Lotfi MH, Yazdi MF, Vahedian-Ardakani HA. Arq Gastroenterol; 2016 Mar 05; 53(3):175-9. PubMed ID: 27438423 [Abstract] [Full Text] [Related]
17. Safer Blood Supply for Transfusion: Which Algorithm Should Be Used to Determine Occult Hepatitis B Infection in Blood Donors? Berkem R, Karakoç AE. Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115222 [Abstract] [Full Text] [Related]
18. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Indian J Med Res; 2010 Sep 01; 132():312-7. PubMed ID: 20847378 [Abstract] [Full Text] [Related]
19. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination. Altunay H, Kosan E, Birinci I, Aksoy A, Kirali K, Saribas S, Aslan M, Yuksel P, Alan E, Yenen OS, Kocazeybek B. Transfus Apher Sci; 2010 Dec 01; 43(3):265-268. PubMed ID: 20934912 [Abstract] [Full Text] [Related]
20. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants. Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR. J Viral Hepat; 2011 Oct 01; 18(10):721-9. PubMed ID: 21914087 [Abstract] [Full Text] [Related] Page: [Next] [New Search]